Aleix Prat

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Aleix Prat
Dec 30, 2024, 10:05 | Blog
Translational genomics and targeted therapies in solid tumours - August Pi i Sunyer Biomedical Research Institute
August Pi i Sunyer Biomedical Research Institute - IDIBAPS shared a post on LinkedIn: “The…
Dec 26, 2024, 15:12 | Positive
Celebrating the Holiday Magic with Medical Community
Christmas is a time to cherish connections, reflect on the year gone by, and prepare…
Dec 24, 2024, 13:29 | Science
Francesco Schettini: Which ADC is to prioritise in HR+ and TN BC?
Francesco Schettini, Medical Oncologist at the Breast Unit of the Hospital Clinic of Barcelona and…
Dec 24, 2024, 07:42 | Science
Serena Di Cosimo: The prognostic value of residual tumor biology during neoadjuvant treatment in patients with HER2+ breast cancer
Serena Di Cosimo, Medical Director at IRCCS Foundation National Cancer Institute, Milan, shared a recent…
Dec 22, 2024, 15:16 | Blog
Aleix Prat: Christmas Celebration at Cancer and Blood Diseases Institute of Barcelona Comprehensive Cancer Center
Aleix Prat, Director of the Cancer Institute at the Hospital Clinic of Barcelona, shared a…
Dec 22, 2024, 12:54 | Science
Aleix Prat: ADCs in pretreated HER2-low metastatic breast cancer
Aleix Prat, Director of the Cancer Institute at the Hospital Clinic of Barcelona, shared a…
Dec 21, 2024, 11:27 | Blog
Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona
Aleix Prat shared a post on LinkedIn: "Congratulations to Carlos Fernandez de Larrea We are proud…
Dec 19, 2024, 02:34 | Blog
Javier Muñoz Carrillo: First-hand presentation of cutting-edge clinical trial results in breast cancer research at SABCS24
Javier Muñoz Carrillo, Medical Oncology Resident at University of Barcelona, shared a post on LinkedIn:…
Dec 15, 2024, 14:21 | Blog
Aleix Prat: Which biomarker predicts best OS in early stage TNBC?
Aleix Prat, Director of the Cancer Institute at the Hospital Clinic of Barcelona, shared on…
Dec 15, 2024, 02:46 | Blog
Aleix Prat: Our DNADX plasma-based assay in 160 patients with metastatic breast cancer
Aleix Prat, Director of the Cancer Institute at the Hospital Clinic of Barcelona, shared a…
Dec 14, 2024, 15:44 | Blog
Sara Tolaney: First line treatment approaches in HER2+ BC
Sara Tolaney, Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, shared a…
Dec 13, 2024, 17:04 | Insight
Sana Sukhun: SHR-A1811 demonstrating non-inferiority to the standard quadruple therapy in early Breast Cancer
Sana Sukhun, Co-Chair of RSG Committee of ASCO for Metastatic Breast Cancer, made the following…
Dec 12, 2024, 16:51 | Insight
Insights from SABCS24 by Matteo Lambertini
The San Antonio Breast Cancer Symposium (SABCS) 2024 is taking place from December 10-13 in…
Dec 12, 2024, 08:04 | Insight
Highlights from Day 1 of SABCS 2024 by Sara Tolaney
The SABCS 2024 (San Antonio Breast Cancer Symposium) is taking place from December 10th to…
Dec 10, 2024, 16:07 | Opinion
Breast Cancer Research Digest by Dana-Farber Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared on X: “Here’s the Breast Cancer Research Digest - a…
Dec 4, 2024, 10:39 | Insight
Elisa Agostinetto: The Results of the NEOENDO Translational Study by Francesco Schettini, et al.
Elisa Agostinetto, Medical Research Fellow at the University Hospital of Brussels, shared an article by…
Oct 29, 2024, 13:05 | Insight
Paolo Tarantino: My 100th scientific publication
Paolo Tarantino, Fellow at Dana-Farber Cancer Institute, shared a post on X: "It turns out…
Oct 8, 2024, 10:55 | Blog
Aleix Prat: The high costs of anticancer therapies in the USA
Aleix Prat shared the following on X: “The high costs of anticancer therapies in the…
Oct 7, 2024, 07:17 | Blog
Aleix Prat: Breast Cancer Statistics 2024 from American Cancer Society
Aleix Prat shared a post on X: "Breast Cancer Statistics 2024 -- American Cancer Society. "Breast…
Sep 29, 2024, 15:48 | Blog
Elisabetta Bonzano: Dual HER2 inhibition, mechanisms of synergy
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X: "Dual HER2 inhibition:…
Sep 18, 2024, 23:03 | Insight
Aleix Prat: Dual HER2 inhibition in Breast Cancer
Aleix Prat shared a post on X about a recent paper by Adrienne Waks et…
Sep 1, 2024, 15:26 | Insight
Guillermo Villacampa: Meta-analysis evaluating immunotherapy in early breast cancer
Recently, an article by Guillermo Villacampa et al. was published in JAMA Oncology. "Neoadjuvant Immune…
Aug 23, 2024, 15:59 | Drugs
Aleix Prat: Our recent article on patritumab deruxtecan is on the list of Nature Communications' Editors’ Highlights
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared a post…
Jul 29, 2024, 11:19 | Insight
Rasha Aboelhassan: We can give TDM1 in stage I HER2 positive breast cancer
Rasha Aboelhassan shared a post on LinkedIn about a recent paper by Paolo Tarantino et al., commenting:…
Jul 25, 2024, 12:07 | Insight
Sonia Guedan: CAR affinity modulates CAR-T cells' sensitivity to PD-1/PD-L1 inhibition
Sonia Guedan, shared a post on X about a recent paper titled "CAR affinity modulates the…
Jul 25, 2024, 03:18 | Insight
6th and 7th ABC international consensus guidelines for the management of advanced breast cancer
ABC Global Alliance shared on LinkedIn: “Inequalities in access to care are a major hurdle…
Jul 22, 2024, 23:09 | Blog
Aleix Prat: TNBC-DX - new genomic profiling tool for the treatment of early-stage triple-negative breast cancer (TNBC)
Aleix Prat, Director of Cancer Institute and Blood Disorders at Clinical Hospital of Barcelona, shared…
Jul 22, 2024, 20:26 | Insight
How tumor biology impacts Patritumab deruxtecan's efficacy in early breast cancer
Sonia Guedan, Cancer Immunologist at Hospital Clinic Barcelona, posted on X: "Our colleague Aleix Prat's…
Jul 20, 2024, 11:01 | Insight
Paolo Tarantino: Thanks to ESMO for featuring our 5-year analysis of the ATEMPT randomized phase 3 trial
Paolo Tarantino shared a post on LinkedIn about a paper titled "Adjuvant Trastuzumab Emtansine Versus…
Jul 17, 2024, 12:35 | Insight
Aleix Prat: Our review article about HR+ breast cancer in young women
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared a post…
Jul 16, 2024, 23:13 | Blog
Benjamin Walbaum: Hormone receptor-positive early breast cancer in young women
Recently an article about: Hormone receptor-positive early breast cancer in young women: A comprehensive review…
Jul 15, 2024, 12:03 | Insight
Aleix Prat: Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared a post…
Jul 3, 2024, 22:59 | Blog
Aleix Prat: Our 2 articles published this week
Aleix Prat, Head of the Medical Oncology Department at Hospital Clínic Barcelona, shared on X:…
Jul 1, 2024, 15:23 | Insight
Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial
Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…
Jun 14, 2024, 13:52 | Blog
Maria Vidal: Grateful to Ann Partridge and her team at DFCI for this amazing opportunity
Maria Vidal, Medical Oncologist at Hospital Clinic and IOB Institute of Oncology Barcelona, shared a…
May 31, 2024, 17:02 | Insight
Yakup Ergün: A guide where we can find answers to every question about aBC
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared a post on…
May 19, 2024, 09:02 | Blog
Aleix Prat: HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants
Aleix Prat, CoFounder of Reveal Genomics, shared a post on X: "HER2‐low breast cancer in young…
May 19, 2024, 06:29 | Blog
Aleix Prat: EVOMET Conference: ‘Deconstructing the evolution of metastasis’  
Aleix Prat, CoFounder of Reveal Genomics, shared a post on X: "EVOMET Conference: ‘Deconstructing the evolution…
May 7, 2024, 03:53 | Blog
Aleix Prat: Dr. Tomás Pascual, will be co-presenting an educational talk alongside Sara Tolaney and Tatiana Prowell
Aleix Prat, Director of the Oncology Institute at Hospital Clínic Barcelona, shared a post on X:…
Apr 30, 2024, 05:53 | Blog
Paolo Tarantino: Grateful to e-join SIOM 2024!
Paolo Tarantino shared a post by Sarah Sammons, Medical Oncologist at Dana-Farber’s Breast Oncology Center…
Apr 28, 2024, 05:14 | Insight
Aleix Prat: Our new article about attitudes towards HER2DX in Spain
Aleix Prat, Director of the Cancer Institute at Hospital Clinic of Barcelona, shared on X/Twitter:…
Apr 22, 2024, 11:46 | Blog
Paolo Tarantino: The unmissable Harvard University breast cancer course is coming back on July 11-12
Paolo Tarantino, Research Fellow at Dana Farber Cancer Institute, shared on X: "The unmissable Harvard…
Apr 22, 2024, 11:40 | Blog
Sara Tolaney: Very excited to have Aleix Prat as the Schlager Lecturer at the Harvard Breast Course in July!
Sara Tolaney shared a post by Aleix Prat, Co-Founder of Reveal Genomics, on X/Twitter, adding:…
Jan 2, 2024, 18:10 | Insight
Aleix Prat: Excited to unveil our lab's TOP-11 2023 research articles in breast cancer
Aleix Prat, Director of Cancer Institute at Hospital Clinic of Barcelona, shared on LinkedIn: "Excited to…
All: 44 Posts: 1 - 100
Special Coverage